Urine test may predict who benefits from prostate surgery
NCT ID NCT07416981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a protein called CTGF in urine can indicate bladder scarring and predict how well men recover after surgery for an enlarged prostate. Researchers will measure CTGF levels before surgery in 50 men and compare them to their outcomes. The goal is to find a non-invasive way to guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple urine test to predict which patients will benefit most from surgery for prostate obstruction.
- What could go wrong
- This is a small, early observational study, not a treatment trial. The biomarker may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a tiny scrotal procedure ease prostate troubles without surgery?
- Do common prostate drugs change the eye? a trial investigates
- Can a common prostate drug spare the eye during cataract surgery?
- Can needles ease Post-Surgery bladder troubles? a trial puts electroacupuncture to the test
- Can a Drug-Coated balloon ease an enlarged prostate without surgery?
- Does anesthesia choice affect clotting in prostate surgery? a trial investigates